N. prodotti: 0
Totale ordine: € 0,00
Online ISSN 1827-1707
Sansone V. 1, 2, Consonni O. 1, 2, Maiorano E. 1, 2
1 Orthopaedic Department University of Milan, Milan, Italy;
2 Istituto Ortopedico Galeazzi IRCCS, Milan, Italy
There are many dietary supplements, chondroprotective agents, disease-modifying agents and nutraceuticals that have been developed and promoted for treating patients affected by osteoarthritis (OA). They can be, and often are, marketed without undergoing a rigorous scientific evaluation. In the literature several in vitro- or in vivo-trials concerning these compounds can be found, but there is a lack of high-quality, long-term, prospective, comparative studies able to demonstrate unequivocally their effectiveness in the treatment of OA. This is a narrative review concerning the commonest chondroprotective agents found on the market, and assesses whether, on the basis of the current literature, these agents may have a role in the treatment of OA.